USX:BCAB - BioAtla Inc BioAtla Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 22 Mar 2022
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 25.25    +1.430 (+6.00%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

30 Nov 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Jay M. Short

IPO: 2020-12-16

Headquarters: US

Employees: 36

Homepage

Description

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.